Logo

American Heart Association

  40
  0


Final ID: P-345

Long-Term Blood Pressure Variability and Physical Performance Measures in Community-Dwelling Older Adults

Abstract Body: High degrees of long-term, visit-to-visit blood pressure variability (BPV) independently predict increased risks of cardiovascular disease, cognitive decline, and frailty in older adults. Measures of physical performance such as gait speed and grip strength can predict loss of independence and mortality in older adults, but are not routinely measured in practice. Shared pathways of underlying physiologic deterioration may exist between high BPV and progressive loss of gait speed and grip strength. We examined the association between long term, visit-to-visit BPV and change in gait speed and grip strength in participants of the ASPirin in Reducing Events in the Elderly (ASPREE) study, a randomized primary prevention trial of low-dose aspirin conducted in 19,114 community-dwelling adults in Australia and the U.S. who were without independence-limiting physical disability at enrollment, and its extended long-term observational follow-up (ASPREE-XT). Long-term BPV was estimated in each participant using the standard deviation (SD) of the means of three within-visit systolic BPs obtained using a validated automated oscillometric BP monitor from the baseline and first two annual ASPREE visits. During ASPREE and continued into ASPREE-XT, participants underwent annual/biennial measures of grip strength using a Jamar hand grip dynamometer, and completed a timed 3 meter walk at normal pace. Linear mixed models were used to examine changes in gait speed and grip strength trajectories over a median of 5.2 years of follow-up after the second annual ASPREE visit (end of BPV estimation window). After covariate adjustment, the highest SD tertile of BPV, compared to the lowest SD tertile, was associated with greater declines in gait speed over time, and reduced grip strength cross-sectionally (see accompanying Table). Our findings suggest that long-term BPV is an important predictor of progressive loss of physical performance, particularly gait speed, in older adults. Since BP is routinely measured in practice, characterization of the visit-to-visit BPV may help identify older adults at risk of future declines in physical function and loss of independence.
  • Ernst, Michael  ( University of Iowa , Iowa City , Iowa , United States )
  • Wolfe, Rory  ( Monash University , Melbourne , Victoria , Australia )
  • Murray, Anne  ( Hennepin Health Care , Edina , Minnesota , United States )
  • Ryan, Joanne  ( Monash University , Melbourne , Victoria , Australia )
  • Shah, Raj  ( Rush University Medical Center , Chicago , Illinois , United States )
  • Polkinghorne, Kevan  ( Monash University , Melbourne , Victoria , Australia )
  • Reid, Christopher  ( Curtin University , Perth , Western Australia , Australia )
  • Webb, Katherine  ( Monash University , Melbourne , Victoria , Australia )
  • Sheets, Kerry  ( Hennepin Health Care , Edina , Minnesota , United States )
  • Woods, Robyn  ( Monash University , Melbourne , Victoria , Australia )
  • Fravel, Michelle  ( University of Iowa , Iowa City , Iowa , United States )
  • Beilin, Lawrence  ( University of Western Australia , Perth , Western Australia , Australia )
  • Espinoza, Sara  ( Cedars-Sinai , Los Angeles , California , United States )
  • Orchard, Suzanne  ( Monash University , Melbourne , Victoria , Australia )
  • Owen, Alice  ( Monash University , Melbourne , Victoria , Australia )
  • Author Disclosures:
    Michael Ernst: DO NOT have relevant financial relationships | Rory Wolfe: DO NOT have relevant financial relationships | Anne Murray: DO NOT have relevant financial relationships | Joanne Ryan: No Answer | Raj Shah: DO have relevant financial relationships ; Research Funding (PI or named investigator):Amylyx Pharmaceuticals, Inc.:Past (completed) ; Research Funding (PI or named investigator):Genentech, Inc.:Active (exists now) ; Research Funding (PI or named investigator):Eli Lilly & Co., Inc.:Active (exists now) ; Research Funding (PI or named investigator):Edgewater NEXT:Past (completed) ; Research Funding (PI or named investigator):Athira Pharma, Inc.:Active (exists now) | Kevan Polkinghorne: No Answer | Christopher Reid: No Answer | Katherine Webb: DO NOT have relevant financial relationships | Kerry Sheets: DO NOT have relevant financial relationships | Robyn Woods: DO NOT have relevant financial relationships | Michelle Fravel: DO NOT have relevant financial relationships | Lawrence Beilin: DO NOT have relevant financial relationships | Sara Espinoza: No Answer | Suzanne Orchard: DO NOT have relevant financial relationships | alice owen: No Answer
Meeting Info:
Session Info:

Poster Session 2

Friday, 09/06/2024 , 09:00AM - 10:30AM

Poster Session

More abstracts on this topic:
CASC15 lncRNA as a Mediator of Vascular Senescence in the Renin-Angiotensin System

Cunha Warlley, Martin Maria, Ahmed Ibrahim, Gomez Delphine, Espinosa-diez Cristina

Endothelial-specific PHD2 Modulates Cardiac Inflammation, Hypertrophy, and Dysfunction in an Age-dependent Manner

He Xiaochen, Xu Rui, Bhattarai Umesh, Pan Lihong, Wang Dongzhi, Niu Ziru, Zeng Heng, Chen Jian-xiong, Chen Yingjie

More abstracts from these authors:
APOe Genotype Modifies the Association Between Long-Term Blood Pressure Variability and Cognitive Decline/Dementia in Older Adults

Ernst Michael, Wolfe Rory, Murray Anne, Shah Raj, Polkinghorne Kevan, Reid Christopher, Lacaze Paul, Ryan Joanne, Webb Katherine, Sheets Kerry, Woods Robyn, Fravel Michelle, Beilin Lawrence, Espinoza Sara, Orchard Suzanne, Owen Alice

A Remote Pharmacist Intervention for Monitoring and Treating Hypertension for Patients Living in Rural Areas

Carter Barry, Simmering Jacob, Francis Shelby, Sewell Daniel, Finkelstein Rachel, Ernst Michael, Polgreen Philip, Polgreen Linnea

You have to be authorized to contact abstract author. Please, Login
Not Available